{"id":"3e1087cf-f6af-5d7a-ba8f-e165ba04f3e8","stable_key":"46d15d9e-d3b5-544d-ba01-b785aa3e4f42:b1-slc25a19-neuropathy-genetics","predicate":"associated-with","statement":"Four SLC25A19-affected patients had episodic paralysis/encephalopathy and progressive polyneuropathy with bilateral striatal necrosis.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"9a469e20-de6d-5293-8e06-533da819c066","mechanism_event_label":"Mitochondrial B1 transport disease can present after normal early development.","subject":{"id":"5c60b542-d507-5d22-bc41-e71956c79239","slug":"slc25a19-neuropathy-genotype","display_name":"SLC25A19 neuropathy family genotype","entity_type_key":"gene"},"object":{"id":"a6383eb8-a7a4-5ed8-8dfc-0ba8c3ff145b","slug":"slc25a19-neuropathy-phenotype","display_name":"SLC25A19 neuropathy and striatal injury phenotype","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"9a469e20-de6d-5293-8e06-533da819c066","stable_key":"46d15d9e-d3b5-544d-ba01-b785aa3e4f42:b1-slc25a19-neuropathy-genetics-event","event_type":"observed_intervention","label":"Mitochondrial B1 transport disease can present after normal early development.","description":"Four SLC25A19-affected patients had episodic paralysis/encephalopathy and progressive polyneuropathy with bilateral striatal necrosis.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"3f719fb0-6cf0-574a-a56f-3c43dfcb681a","slug":"slc25a19","display_name":"Human mitochondrial thiamine diphosphate transporter / SLC25A19","entity_type_key":"protein"},"role":"affected carrier","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"187db168-8028-5ce6-9f8b-4bc61ebad1a0","slug":"thiamine-diphosphate","display_name":"Thiamine diphosphate","entity_type_key":"small_molecule"},"role":"normal substrate","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"5c60b542-d507-5d22-bc41-e71956c79239","slug":"slc25a19-neuropathy-genotype","display_name":"SLC25A19 neuropathy family genotype","entity_type_key":"gene"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"a6383eb8-a7a4-5ed8-8dfc-0ba8c3ff145b","slug":"slc25a19-neuropathy-phenotype","display_name":"SLC25A19 neuropathy and striatal injury phenotype","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence-scope","value_text":"Neurological phenotype","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_locator","value_text":"Abstract","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_spans","value_text":"[{\"source_document\": \"artifacts/thiamine_transport_sources/spiegel-2009-slc25a19-neuropathy-source-record.json\", \"source_field\": \"resultList.result[0].abstractText\", \"start_char\": 0, \"end_char\": 774}]","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Four patients aged 7-20; homozygosity mapping and clinical characterization.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Normal head circumference and urinary organic acids in this family do not describe every variant.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Thiamine research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"thiamine","display_name":"Thiamine (vitamin B1)","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Homo sapiens","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Mitochondrial B1 transport disease can present after normal early development.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[spiegel-2009-slc25a19-neuropathy] SLC25A19 mutation as a cause of neuropathy and bilateral striatal necrosis (2009). https://pubmed.ncbi.nlm.nih.gov/19798730/ DOI: 10.1002/ana.21752","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Neurological phenotype","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"4c1e8340-9122-5aa2-bc3b-acbe4e5eb490","evidence_kind":"source_excerpt","locator":"Lines 488-500","start_line":488,"end_line":500,"excerpt":"### b1-slc25a19-neuropathy-genetics\nFour SLC25A19-affected patients had episodic paralysis/encephalopathy and progressive polyneuropathy with bilateral striatal necrosis.\nCondition category: machinery_impairment\nnutrient_topic: Thiamine research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: Mitochondrial B1 transport disease can present after normal early development.\norganism: Homo sapiens\ntissue_or_cell_type: Neurological phenotype\nexperimental_model: Four patients aged 7-20; homozygosity mapping and clinical characterization.\nlimitations: Normal head circumference and urinary organic acids in this family do not describe every variant.\nevidence_spans: [{\"source_document\": \"artifacts/thiamine_transport_sources/spiegel-2009-slc25a19-neuropathy-source-record.json\", \"source_field\": \"resultList.result[0].abstractText\", \"start_char\": 0, \"end_char\": 774}]\nevidence_locator: Abstract\nevidence-scope: Neurological phenotype\n[spiegel-2009-slc25a19-neuropathy] SLC25A19 mutation as a cause of neuropathy and bilateral striatal necrosis (2009). https://pubmed.ncbi.nlm.nih.gov/19798730/ DOI: 10.1002/ana.21752","model_system":"Four patients aged 7-20; homozygosity mapping and clinical characterization.","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [spiegel-2009-slc25a19-neuropathy] SLC25A19 mutation as a cause of neuropathy and bilateral striatal necrosis (2009). https://pubmed.ncbi.nlm.nih.gov/19798730/ DOI: 10.1002/ana.21752","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"158d2c03-ac8c-589f-8270-c468165ae346","stable_key":"import-46d15d9e-d3b5-544d-ba01-b785aa3e4f42","title":"Thiamine: mechanisms, deficiency and nutrient interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"f376512fb3310141315548015b387833e3af45146e73fb73cd02cee20e4ddb9c","revision_id":"53bc5eda-dec8-58cc-a56f-a9eb4ab036ef","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}